Chemotherapy-Associated Osteonecrosis in Cancer Patients with Solid Tumours: A Systematic ReviewSHIM, Katharine; MACKENZIE, Mary J; WINQUIST, Eric et al.Drug safety. 2008, Vol 31, Num 5, pp 359-371, issn 0114-5916, 13 p.Article

Nontraumatic osteonecrosis after chemotherapy for testicular cancer: A systematic reviewWINQUIST, Eric W; BAUMAN, Glenn S; BALOGH, Judith et al.American journal of clinical oncology. 2001, Vol 24, Num 6, pp 603-606, issn 0277-3732Article

Primary synovial sarcoma of the kidney diagnosed by molecular detection of SYT-SSX fusion transcriptsBELLA, Anthony J; WINQUIST, Eric W; PERLMAN, Elizabeth J et al.The Journal of urology. 2002, Vol 168, Num 3, pp 1092-1093, issn 0022-5347Article

Plasma osteopontin levels are predictive of disease stage in patients with transitional cell carcinoma of the bladderANG, Celina; CHAMBERS, Ann F; TUCK, Alan B et al.BJU international (Papier). 2005, Vol 96, Num 6, pp 803-805, issn 1464-4096, 3 p.Article

Malignant pheochromocytoma associated with germline mutation of the SDHB geneALLIBHAI, Zishan; RODRIGUES, George; BRECEVIC, E. D et al.The Journal of urology. 2004, Vol 172, Num 4, pp 1409-1410, issn 0022-5347, 2 p., 1Article

Effect of Selenium and Vitamin E on Risk of Prostate Cancer and Other Cancers : The Selenium and Vitamin E Cancer Prevention Trial (SELECT)LIPPMAN, Scott M; KLEIN, Eric A; KELLOGG PARSONS, J et al.JAMA, the journal of the American Medical Association. 2009, Vol 301, Num 1, pp 39-51, issn 0098-7484, 13 p.Article

FLUORESCENCE IN SITU HYBRIDIZATION GENE AMPLIFICATION ANALYSIS OF EGFR AND HER2 IN PATIENTS WITH MALIGNANT SALIVARY GLAND TUMORS TREATED WITH LAPATINIBVIDAL, Laura; TSAO, Ming S; HAYES, D. Neil et al.Head & neck. 2009, Vol 31, Num 8, pp 1006-1012, issn 1043-3074, 7 p.Article

Phase II study of lapatinib in recurrent or metastatic epidermal growth factor receptor and/or erbB2 expressing adenoid cystic carcinoma and non-adenoid cystic carcinoma malignant tumors of the salivary glandsAGULNIK, Mark; COHEN, Ezra W. E; BROWN, Shirley et al.Journal of clinical oncology. 2007, Vol 25, Num 25, pp 3978-3984, issn 0732-183X, 7 p.Article

Application of a Policy Framework for the Public Funding of Drugs for Rare DiseasesWINQUIST, Eric; COYLE, Doug; CLARKE, Joe T. R et al.Journal of general internal medicine. 2014, Vol 29, issn 0884-8734, S774-S779, SUP3Article

Toward a Functional Definition of a Rare Disease for Regulatory Authorities and Funding AgenciesCLARKE, Joe T. R; COYLE, Doug; EVANS, Gerald et al.Value in health. 2014, Vol 17, Num 8, pp 757-761, issn 1098-3015, 5 p.Article

New Dual Monoclonal ELISA for Measuring Plasma Osteopontin as a Biomarker Associated with Survival in Prostate Cancer: Clinical Validation and Comparison of Multiple ELISAsANBORGH, Pieter H; WILSON, Sylvia M; CHAMBERS, Ann F et al.Clinical chemistry (Baltimore, Md.). 2009, Vol 55, Num 5, pp 895-903, issn 0009-9147, 9 p.Article

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancerPOSNER, Marshall R; HERSHOCK, Diane M; MURPHY, Barbara A et al.The New England journal of medicine. 2007, Vol 357, Num 17, pp 1705-1715, issn 0028-4793, 11 p.Article

Detection of circulating tumor cells in advanced head and neck cancer using the cellsearch systemNICHOLS, Anthony C; LOWES, Lori E; PALMA, David A et al.Head & neck. 2012, Vol 34, Num 10, pp 1440-1444, issn 1043-3074, 5 p.Article

Exemestane for Breast-Cancer Prevention in Postmenopausal WomenGOSS, Paul E; INGLE, James N; WINQUIST, Eric et al.The New England journal of medicine. 2011, Vol 364, Num 25, pp 2381-2391, issn 0028-4793, 11 p.Article

A Phase 2 Study of Platinum and Gemcitabine in Patients With Advanced Salivary Gland Cancer: A Trial of the NCIC Clinical Trials GroupLAURIE, Scott A; SIU, Lillian L; WINQUIST, Eric et al.Cancer. 2010, Vol 116, Num 2, pp 362-368, issn 0008-543X, 7 p.Article

Predictive and pharmacodynamic biomarker studies in tumor and skin tissue samples of patients with recurrent or metastatic squamous cell carcinoma of the head and neck treated with erlotinibAGULNIK, Mark; DA CUNHA SANTOS, Gilda; WINQUIST, Eric et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2184-2190, issn 0732-183X, 7 p.Article

Neoadjuvant chemotherapy for transitional cell carcinoma of the bladder: A systematic review and meta-analysisWINQUIST, Eric; KIRCHNER, Tricia S; SEGAL, Roanne et al.The Journal of urology. 2004, Vol 171, Num 2, pp 561-569, issn 0022-5347, 9 p., 1Article

Feasibility of real time next generation sequencing of cancer genes linked to drug response: Results from a clinical trialTRAN, Ben; BROWN, Andrew M. K; FERRETTI, Vincent et al.International journal of cancer (Print). 2013, Vol 132, Num 7, pp 1547-1555, issn 0020-7136, 9 p.Article

Nomograms to Predict Serious Adverse Events in Phase II Clinical Trials of Molecularly Targeted AgentsPOND, Gregory R; SIU, Lillian L; MOORE, Malcolm et al.Journal of clinical oncology. 2008, Vol 26, Num 8, pp 1324-1330, issn 0732-183X, 7 p.Article

Phase I/II trial of erlotinib and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck: A Princess Margaret Hospital phase II consortium and National Cancer Institute of Canada Clinical Trials Group StudySIU, Lillian L; SOULIERES, Denis; EISENHAUER, Elizabeth A et al.Journal of clinical oncology. 2007, Vol 25, Num 16, pp 2178-2183, issn 0732-183X, 6 p.Article

Phase II trial of sorafenib in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or nasopharyngeal carcinomaELSER, Christine; SIU, Lillian L; WILKIE, Dean et al.Journal of clinical oncology. 2007, Vol 25, Num 24, pp 3766-3773, issn 0732-183X, 8 p.Article

A multinomial phase II study of lonafamib (SCH 66336) in patients with refractory urothelial cancerWINQUIST, Eric; MOORE, Malcolm J; SEYMOUR, Lesley et al.Urologic oncology. 2005, Vol 23, Num 3, pp 143-149, issn 1078-1439, 7 p.Article

A phase II study of oxaliplatin in urothelial cancerWINQUIST, Eric; VOKES, Everett; MOORE, Malcolm J et al.Urologic oncology. 2005, Vol 23, Num 3, pp 150-154, issn 1078-1439, 5 p.Article

Temporal changes in the efficacy of chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck: A systematic review and meta-analysisWINQUIST, Eric; AL-RASHEEDY, Intisar; NICHOLS, Anthony C et al.Cancer treatment reviews. 2014, Vol 40, Num 9, pp 1073-1079, issn 0305-7372, 7 p.Article

Abiraterone in Metastatic Prostate Cancer without Previous ChemotherapyRYAN, Charles J; SMITH, Matthew R; CARLES, Joan et al.The New England journal of medicine. 2013, Vol 368, Num 2, pp 138-148, issn 0028-4793, 11 p.Article